# Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation

> **NCT02450799** · NA · COMPLETED · sponsor: **Alcon, a Novartis Company** · enrollment: 104 (actual)

## Conditions studied

- Pseudophakia

## Interventions

- **DEVICE:** Acrylic IOL
- **DEVICE:** Silicone IOL
- **DEVICE:** PMMA IOL

## Key facts

- **NCT ID:** NCT02450799
- **Lead sponsor:** Alcon, a Novartis Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2016-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02450799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02450799, "Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02450799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*